This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Renascience Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovations of Akihisa Maeda: A Pioneer in PAI-1 Inhibition
Introduction
Akihisa Maeda is a noteworthy inventor based in Osaka, Japan. He has made significant strides in the field of medical research, particularly through his groundbreaking work on plasminogen activator inhibitor-1 (PAI-1).
Latest Patents
Maeda holds a patent for a novel compound that exhibits inhibitory activity against PAI-1. This innovative compound is not only pivotal in understanding its biological implications but also serves as the active ingredient in an inhibitor of PAI-1. The patent emphasizes the potential of this inhibitor in the development of pharmaceutical compositions aimed at preventing and treating various diseases linked to PAI-1 activity.
Career Highlights
Maeda is associated with Renascience Co., Ltd., where he has been instrumental in advancing the organization's research endeavors. His singular patent reflects his deep commitment to exploring therapeutic avenues that can alleviate diseases' onset influenced by PAI-1.
Collaborations
Throughout his career, Akihisa Maeda has collaborated with notable colleagues such as Toshio Miyata and Kenji Murano. These partnerships have fostered an environment of innovation and research excellence, enhancing their collective ability to address pressing health issues.
Conclusion
Akihisa Maeda's contributions to the field of medical research exemplify the vital role of inventors in advancing healthcare. His patent on PAI-1 inhibitors not only showcases his inventiveness but also holds promise for significant medical advances in disease prevention and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile